[Anticancer drug research in Hungary, 1950-2000].

Autor: Jeney A; I. Sz. Patológiai és Kísérleti Rákkutató Intézet, Semmelweis Egyetem, Budapest, Hungary. ajeney@korb1.sote.hu., Kralovánszky J; I. Sz. Patológiai és Kísérleti Rákkutató Intézet, Semmelweis Egyetem, Budapest, Hungary. ajeney@korb1.sote.hu., Lapis K; I. Sz. Patológiai és Kísérleti Rákkutató Intézet, Semmelweis Egyetem, Budapest, Hungary. ajeney@korb1.sote.hu.

Publikováno v: Magyar onkologia [Magy Onkol] 2017 Dec 18; Vol. 61 (4), pp. 375-382. Date of Electronic Publication: 2017 Nov 30.

The biological activity of cisplatin and dibromodulcitol in combination therapy.

Autor: Jeney A; Institute of Pathology and Experimental Cancer Research, Semmelweis University of Medicine Budapest, Hungary., Kovalszky I, Rásó E, Durand RE, Fürész J, Lapis K

Publikováno v: British journal of cancer [Br J Cancer] 1995 Feb; Vol. 71 (2), pp. 317-21.

Pharmacokinetic studies on Elobromol in children with brain tumors.

Autor: Paál C; Second Department of Pediatrics, Semmelweis Medical School, Budapest, Hungary., Erdélyi-Tóth V, Pap E, Csáki C, Ferencz T, Schuler D, Borsi JD

Publikováno v: Anti-cancer drugs [Anticancer Drugs] 1994 Oct; Vol. 5 (5), pp. 539-47.

The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol.

Autor: Szende B; 1st Institute of Pathology and Experimental Cancer Research, Semmelweis University Medical School Budapest, Hungary., Jeney A, Institoris L

Publikováno v: Acta morphologica Hungarica [Acta Morphol Hung] 1992; Vol. 40 (1-4), pp. 187-93.

A network meta-analysis: the overall and progression-free survival of glioma patients treated by different chemotherapeutic interventions combined with radiation therapy (RT).

Autor: Qi L; Basic Medical College, Jilin Medical University, Jilin, China., Ding L; Department of Radiation Oncology, First Hospital of Jilin University, Changchun, China., Wang S; Department of Science and Technology, Jilin Medical University, Jilin, China., Zhong Y; Department of Science and Technology, Jilin Medical University, Jilin, China., Zhao D; Department of Science and Technology, Jilin Medical University, Jilin, China., Gao L; Department of Radiation Oncology, First Hospital of Jilin University, Changchun, China., Wang W; Basic Medical College, Jilin Medical University, Jilin, China., Lv P; Basic Medical College, Jilin Medical University, Jilin, China., Xu Y; Basic Medical College, Jilin Medical University, Jilin, China., Wang S; Center of Cardiovascular Diseases, First Hospital of Jilin University, Changchun, China.

Publikováno v: Oncotarget [Oncotarget] 2016 Oct 18; Vol. 7 (42), pp. 69002-69013.